The pharma industry is starting to use AI and ML to accelerate drug discovery by moving in vitro testing to in silico testing, which allows for predictive modeling of large molecules and can greatly enhance the value and trajectory of a company. Enterprise software businesses that offer broad toolsets and toolkits that allow for revenue sharing or participation in service revenue streams are also becoming more prominent in the industry.